Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:2908-2909
Published online before print June 4, 2009, doi: 10.1161/STROKEAHA.109.552885
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/8/2908    most recent
STROKEAHA.109.552885v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Schäbitz, W.-R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schäbitz, W.-R.
Related Collections
Right arrow Thrombolysis
Right arrowRelated Articles

(Stroke. 2009;40:2908.)
© 2009 American Heart Association, Inc.


Controversies in Stroke

MR Mismatch Is Useful for Patient Selection for Thrombolysis

No

Wolf-Rüdiger Schäbitz, MD

From the Department of Neurology, University of Münster, and EVK Bielefeld, Germany.

Correspondence to W.-R. Schäbitz, EVK Bielefeld, Neurologische Klinik, Burgsteig 13, 33617 Bielefeld, Germany. E-mail wolf.schaebitz@evkb.de


Key Words: diffusion-weighted imaging • thrombolysis • MR mismatch • controversies


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

The clinical constellation of a large MCA stroke with a substantial mismatch between DWI and PWI in the 3- to 6-hour time window is for many stroke neurologists an indication for the off-label use of intravenous t-PA. Clinical practice, however, frequently shows that a significant mismatch can persist for days and that such patients typically improve without any recanalizing therapy. Mismatch imaging may thus not only identify patients with a salvageable penumbra eligible for thrombolysis but also those who may simply recover on their own. To equate the mismatch in a stroke patient with a treatment indication may therefore not be inappropriate.

The mismatch or the penumbra imaging concept was developed by experimental studies and translated into human stroke almost a decade ago. Until today several hundred patients were investigated mainly in smaller unblinded and nonrandomized studies. These data suggested that in patients with a mismatch in the 3- to 6-hour time window thrombolysis may hasten recanalization and reperfusion, possibly reducing infarct growth and improving clinical outcome.1 Unfortunately, in the recently published first-ever randomized controlled study in this context (EPITHET),2 neither the primary end point—geometric mean relative infarct growth—nor clinical outcome was positive. One explanation might be that sponaneously recovering subjects selected by mismatch MRI dilute the patient samples, a factor at least in part responsible for the negative results in the DIAS 2 trial.

For acute MRI lesions that recover without recanalizing therapy, collateral blood supply probably reflects the most important cause for longterm persistance of penumbral tissue and . . . [Full Text of this Article]


Related Articles:

MR Mismatch Is Useful for Patient Selection for Thrombolysis: Yes
Jochen B. Fiebach and Peter D. Schellinger
Stroke 2009 40: 2906-2907. [Extract] [Full Text] [PDF]

MR Mismatch and Thrombolysis: Appealing but Validation Required
Stephen M. Davis and Geoffrey A. Donnan
Stroke 2009 40: 2910. [Extract] [Full Text] [PDF]